The National Authority for Cancer Control in Libya has announced that more than 33,000 cancer patients were registered through its centralized Muhareb digital platform over the past year, highlighting continued efforts to modernize cancer care and improve access to treatment across the country.
According to the authority, 33,872 patients were added to the platform’s national database, while 33,331 patients received medical and therapeutic services through accredited oncology centers operating in different regions of Libya.
In a statement published on its official Facebook page, the authority said the Muhareb platform processed 434,451 electronic medication transactions, allowing healthcare providers to manage prescriptions and the distribution of specialized cancer medicines through a fully digital system.
The authority also reported that 1,984,993 treatment doses and therapeutic units were distributed through 19 accredited oncology centers and branches nationwide. The network was designed to ensure that cancer medications reach patients efficiently, regardless of their location.
Officials said these achievements were recorded despite the significant challenges facing Libya’s oncology sector, including the increasing number of cancer patients, the need to maintain uninterrupted supplies of specialized medicines, and the continued expansion of treatment services throughout the country.
The authority noted that all of its services are now delivered electronically through the Muhareb platform. The system manages every stage of patient care, from registration and the creation of electronic medical records to data management, prescription processing, and medicine distribution, eliminating the need for paper-based procedures.
According to the authority, the transition to a fully digital system has improved operational efficiency, increased the accuracy of medical records, accelerated administrative procedures, strengthened governance, and enhanced oversight of pharmaceutical supplies.
